Bacher, et al. v. Boehringer Ingelheim Pharmaceuticals, Inc., et al.
| Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation, GlaxoSmithKline LLC, Glaxosmithkline Holdings (Americas), Inc., Pfizer, Inc., Sanofi-Aventis U.S. LLC and Sanofi US Services Inc. |
| Armando Ramos |
| 23-146 |
| January 27, 2023 |
| U.S. Court of Appeals, Second Circuit |
| Other |
Docket Report
RSS Track this Docket
This docket was last retrieved on February 14, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 13 OPPOSITION TO MOTION, [ # 3463468-2 ], [ # 3463516-2 ], [ # 3463534-2 ], [ # 3463566-2 ], [ # 1 ], [ # 3463638-2 ], [ # 3463666-2 ], [ # 3463683-2 ], [ # 3463721-2 ], on behalf of Respondent Beth Bacher, Jerome Jay Berkowitz, Mary Cassidy, John Corwin, Armando Ramos, Rafael Rolon, Roderick Sullivan, Thomas Vazzano and Anne Yost in 23-139, FILED. Service date 02/14/2023 by CM/ECF. [3469075] [23-139, 23-140, 23-141, 23-143, 23-146, 23-147, 23-149, 23-150, 23-152] [Entered: 02/14/2023 03:05 PM] |
| Filing 12 CAPTION, case caption amended to reflect the order dated 02/08/2023, AMENDED.[3466183] [23-146] [Entered: 02/08/2023 06:04 PM] |
| Filing 11 MOTION ORDER, granting motion for case management relief, as detailed in the attached order, [ # 8 ] , FILED. [3466149][11] [23-146]--[Edited 02/09/2023 by RD] [Entered: 02/08/2023 05:04 PM] |
| Filing 8 MOTION, for case management relief, on behalf of Petitioner Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, FILED. Service date 02/06/2023 by CM/ECF. [3464731] [23-146] [Entered: 02/06/2023 06:20 PM] |
| Filing 3 DOCKET SHEET, RECEIVED.[3463612] [23-146] [Entered: 02/03/2023 12:11 PM] |
| Filing 2 DISTRICT COURT ORDER, entered in the district court as docket entry dated 01/17/2023, RECEIVED.[3463611] [23-146] [Entered: 02/03/2023 12:10 PM] |
| Filing 1 MOTION, for leave to appeal, on behalf of Petitioner Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation, GlaxoSmithKline LLC, Glaxosmithkline Holdings (Americas), Inc., Pfizer, Inc., Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, FILED. Service date 01/27/2023 by US mail.[3463610] [23-146] [Entered: 02/03/2023 12:09 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
